SCAMP3 Antibody

What is SCAMP3 and what are its basic structural characteristics?

SCAMP3 (secretory carrier membrane protein 3) is a membrane-localized protein comprising 347 amino acid residues with a molecular mass of 38.3 kDa in its canonical form. The protein exists in two distinct isoforms resulting from alternative splicing. SCAMP3 belongs to the SCAMP protein family and functions primarily in post-Golgi recycling pathways. The protein undergoes various post-translational modifications, notably ubiquitination, which regulates its function and stability. SCAMP3 is also known by synonyms including secretory carrier-associated membrane protein 3, propin 1, and C1orf3 .

What is the tissue distribution pattern of SCAMP3?

SCAMP3 demonstrates widespread expression throughout human tissues, with particularly pronounced levels observed in heart and skeletal muscle. This distribution pattern has been confirmed through both protein detection methods using specific antibodies and transcriptomic analyses. Immunohistochemical studies have successfully detected SCAMP3 in mouse skeletal muscle and heart tissues, confirming its conservation across species .

What is the subcellular localization of SCAMP3?

SCAMP3 primarily localizes to membrane compartments within the cell, particularly those involved in secretory and endocytic pathways. Research indicates that SCAMP3 plays a significant role in the trafficking between early endosomes and the Golgi apparatus. The protein's localization can be dynamically regulated, with evidence suggesting that phosphorylation may influence its subcellular distribution. Its strategic positioning within these membrane systems enables its function in protein transport and recycling .

How does SCAMP3 contribute to protein trafficking and recycling?

SCAMP3 functions as a critical regulator in post-Golgi recycling pathways, mediating the transport of cargo proteins between cellular compartments. Most notably, SCAMP3 facilitates the recycling of proteins from early endosomes back to the Golgi apparatus. This process is particularly important for the Interferon-Induced Transmembrane (IFITM) family of proteins, as SCAMP3 stabilizes IFITM3 by preventing its lysosomal degradation. When SCAMP3 is depleted, this recycling mechanism becomes compromised, resulting in increased lysosomal degradation of IFITM3 and potentially other cargo proteins. This trafficking role positions SCAMP3 as an important mediator of protein homeostasis within the cell .

What is the relationship between SCAMP3 and innate immunity?

SCAMP3 performs a novel function in innate immune responses through multiple mechanisms. Primarily, it stabilizes IFITM3, a critical antiviral protein that restricts a broad range of viruses, by reducing IFITM3's lysosomal degradation. This stabilization enhances cellular antiviral defenses. Additionally, SCAMP3 directly restricts Influenza A Viruses (IAVs) by interfering with the cleavage of Hemagglutinin (HA) in Highly Pathogenic Avian Influenza Viruses (HPAIV). This interference produces virions with reduced entry capabilities into target cells, thereby limiting viral infection. Research also indicates that SCAMP3's expression, phosphorylation state, and localization can be dynamically altered in response to viral challenges, suggesting a regulated role in host defense mechanisms .

What role does SCAMP3 play in cancer biology?

SCAMP3 demonstrates significant involvement in cancer progression across multiple malignancies. High SCAMP3 expression has been documented in invasive ductal carcinoma and inflammatory breast cancer, where normal tissues show minimal expression. SCAMP3 promotes cellular proliferation in hepatocellular carcinoma, glioma, melanoma, and triple-negative breast cancer (TNBC). Experimental silencing of SCAMP3 in TNBC cell lines (MDA-MB-231, MDA-MB-468, and SUM-149) results in decreased proliferation, reduced clonal expansion, and diminished capacity to form tumorspheres. These findings collectively position SCAMP3 as a potential oncogenic driver that enhances cancer cell growth and survival capabilities .

What types of SCAMP3 antibodies are available for research?

SCAMP3 antibodies are available in diverse formats to accommodate various research applications. These include:

The selection spans multiple suppliers with documented reactivity against human and mouse SCAMP3. Antibodies target various epitopes, including the N-terminal region, providing researchers with options for different experimental requirements .

What are the recommended dilution ratios for different applications of SCAMP3 antibodies?

Optimal dilution ratios vary depending on the specific application and the antibody used. Based on validated protocols:

These recommendations serve as starting points, and researchers should perform optimization experiments for their specific samples and protocols. The dilution ratios may need adjustment based on the expression level of SCAMP3 in the target tissue or cell line, and the sensitivity of the detection method employed .

What is the significance of the discrepancy between calculated and observed molecular weights of SCAMP3?

The calculated molecular weight of SCAMP3 is reported as 38.3 kDa, while the observed molecular weight in Western blot applications is often around 33 kDa. This discrepancy may result from several factors:

• Post-translational modifications affecting protein mobility

• Protein folding influencing migration patterns

• Alternative splicing producing different isoforms

• Proteolytic processing in certain cellular contexts

Researchers should be aware of this variation when interpreting Western blot results. The consistent detection of SCAMP3 at approximately 33 kDa across multiple studies and antibodies confirms this as a genuine characteristic rather than an artifact. When validating new antibodies or examining SCAMP3 in novel systems, the expected migration pattern at 33 kDa should be considered the reference standard .

How should researchers optimize Western blot protocols for SCAMP3 detection?

For optimal SCAMP3 detection via Western blot, researchers should implement the following protocol adaptations:

• Sample Preparation: Use RIPA buffer with protease inhibitors for efficient extraction from membrane compartments

• Protein Loading: Load 20-40 μg of total protein per lane for standard cell lines

• Gel Selection: Employ 10-12% polyacrylamide gels for optimal resolution around 33 kDa

• Transfer Conditions: Use semi-dry transfer at 15V for 30 minutes or wet transfer at 100V for 1 hour

• Blocking: Block with 5% non-fat milk or BSA in TBST for 1 hour at room temperature

• Primary Antibody: Apply SCAMP3 antibody at 1:1000-1:3000 dilution, incubate overnight at 4°C

• Secondary Antibody: Use species-appropriate HRP-conjugated antibody at 1:5000-1:10000

• Visualization: Look for the primary band at approximately 33 kDa (not 38.3 kDa)

When validating results, include positive control samples from cell lines with known SCAMP3 expression, such as HuH-7, A549, or K-562 cells, which have been verified to express detectable levels of the protein .

What considerations are important for immunohistochemical detection of SCAMP3?

For successful immunohistochemical detection of SCAMP3 in tissue samples, researchers should address several critical factors:

• Antigen Retrieval: Use TE buffer pH 9.0 as the primary method, with citrate buffer pH 6.0 as an alternative if needed

• Antibody Dilution: Begin with a 1:50-1:500 dilution range depending on tissue type and fixation

• Positive Controls: Include mouse skeletal muscle or heart tissue as validated positive controls

• Detection System: Employ a polymer-based detection system for enhanced sensitivity

• Counterstaining: Use light hematoxylin counterstaining to avoid obscuring membrane signals

• Interpretation: Focus on membrane-associated staining patterns consistent with SCAMP3's subcellular localization

The pattern of SCAMP3 distribution can provide valuable insights into physiological or pathological states, particularly in cancer tissues where altered localization may correlate with disease progression .

How can researchers effectively silence SCAMP3 expression for functional studies?

To investigate SCAMP3 function through loss-of-function approaches, researchers can employ several validated methods:

• siRNA Transfection: Transient knockdown using SCAMP3-targeting siRNA (siSC3) provides rapid reduction in expression levels suitable for acute studies

• CRISPR-Cas9 Genetic Editing: Generate stable SCAMP3 knockout cell lines (SC3KO) for long-term functional studies

• Inducible shRNA Systems: Develop doxycycline-inducible SCAMP3 shRNA systems for temporal control of silencing

• Validation Approaches: Confirm knockdown efficiency through:

  • Western blot analysis (expected 70-90% reduction)

  • qRT-PCR for mRNA quantification

  • Immunofluorescence microscopy to assess cellular expression patterns

Phenotypic effects can be assessed by monitoring changes in proliferation (24, 48, and 72 hours post-silencing), colony formation assays, and tumorsphere formation capacity in cancer cell lines like MDA-MB-231, MDA-MB-468, and SUM-149 TNBC cells .

How is SCAMP3 involved in viral infection mechanisms?

SCAMP3 plays a dual role in viral infection processes, particularly for Influenza A Viruses (IAVs). First, it functions as an antiviral factor by interfering with the cleavage of Hemagglutinin (HA) in Highly Pathogenic Avian Influenza Viruses (HPAIV). This interference generates virions with compromised entry capabilities, reducing infection efficiency. Second, SCAMP3 enhances cellular antiviral defenses by stabilizing IFITM3, a potent restriction factor against multiple viruses. SCAMP3 prevents IFITM3's lysosomal degradation by facilitating its recycling from early endosomes back to the Golgi apparatus. When SCAMP3 is depleted, IFITM3 undergoes accelerated degradation, potentially compromising innate immunity against viral challenges. These mechanisms position SCAMP3 as a significant component of cellular defense against viral pathogens .

What is the evidence linking SCAMP3 to cancer progression?

Substantial evidence connects SCAMP3 to cancer progression across multiple malignancies:

• Expression Patterns: High SCAMP3 expression is documented in invasive ductal carcinoma and inflammatory breast cancer, contrasting with minimal expression in normal tissues

• Functional Studies: Knockdown experiments demonstrate that silencing SCAMP3 in triple-negative breast cancer (TNBC) cell lines reduces:

  • Cellular proliferation

  • Clonal expansion capabilities

  • Tumorsphere formation capacity

• Multi-Cancer Involvement: SCAMP3 promotes cell proliferation in:

  • Hepatocellular carcinoma

  • Glioma

  • Melanoma

  • Breast cancer

These findings collectively suggest that SCAMP3 functions as a potential oncogenic driver that enhances cancer cell growth, survival, and potentially metastatic capabilities. The consistent pattern across diverse cancer types indicates a fundamental role in cellular processes that, when dysregulated, contribute to malignant transformation .

What potential exists for SCAMP3 as a therapeutic target?

SCAMP3's involvement in both cancer progression and viral infection mechanisms presents multiple therapeutic targeting opportunities:

• Oncology Applications:

  • Inhibiting SCAMP3 could suppress cancer cell proliferation

  • Targeting SCAMP3-mediated trafficking could disrupt growth factor receptor recycling

  • Combination with existing therapies might enhance treatment efficacy

• Antiviral Strategies:

  • Enhancing SCAMP3 expression or activity could strengthen cellular defenses against influenza viruses

  • Stabilizing SCAMP3-IFITM3 interactions might boost broad-spectrum antiviral immunity

• Target Validation Requirements:

  • Further characterization of SCAMP3's structure-function relationships

  • Development of specific small molecule modulators

  • Testing in appropriate in vivo disease models

• Potential Challenges:

  • Ensuring specificity within the SCAMP protein family

  • Managing effects on normal cellular processes

  • Identifying patient populations most likely to benefit

The therapeutic development pipeline would require robust validation studies before clinical translation becomes feasible, but SCAMP3's diverse roles make it an intriguing candidate for targeted interventions .

How do post-translational modifications regulate SCAMP3 function?

SCAMP3 undergoes several post-translational modifications (PTMs) that likely regulate its function and interactions. Ubiquitination has been documented as a significant modification, potentially influencing SCAMP3's stability and trafficking roles. Additionally, phosphorylation appears to alter SCAMP3's localization and activity, particularly in response to cellular stresses like viral infection. Future research should address:

• The specific ubiquitination sites and responsible E3 ligases

• The kinases responsible for phosphorylation events

• How these modifications impact SCAMP3's interactions with cargo proteins

• The temporal dynamics of these modifications during cellular responses

• Whether other PTMs (glycosylation, SUMOylation, etc.) also regulate SCAMP3

Understanding these regulatory mechanisms could provide insights into how SCAMP3 function is dynamically controlled in different cellular contexts .

What are the molecular mechanisms underlying SCAMP3's role in receptor trafficking?

SCAMP3 has been implicated in EGFR (Epidermal Growth Factor Receptor) recycling, suggesting a broader role in receptor trafficking that warrants further investigation. Key research questions include:

• How SCAMP3 recognizes and sorts specific cargo receptors

• The protein complexes SCAMP3 forms during different trafficking steps

• The relationship between SCAMP3 and the endosomal sorting complex required for transport (ESCRT)

• How SCAMP3 coordinates with Rab GTPases and other trafficking regulators

• Whether SCAMP3 plays similar roles for diverse receptor families beyond EGFR

Elucidating these mechanisms would enhance our understanding of cellular signaling regulation and potentially reveal new intervention points for diseases involving aberrant receptor signaling .

What are the emerging methodologies for studying SCAMP3 dynamics in living cells?

Advanced techniques are emerging to study SCAMP3 with unprecedented spatial and temporal resolution:

• Live-Cell Imaging Approaches:

  • CRISPR-mediated endogenous tagging with fluorescent proteins

  • Split-GFP complementation to visualize specific interactions

  • FRAP (Fluorescence Recovery After Photobleaching) to measure mobility

• Proximity Labeling Methods:

  • BioID or TurboID fusions to identify the SCAMP3 interactome

  • APEX2-based approaches for temporal interaction mapping

• Super-Resolution Microscopy:

  • STED or PALM imaging to resolve SCAMP3 within membrane microdomains

  • Correlative light and electron microscopy to place SCAMP3 in ultrastructural context

• Functional Genomics Integration:

  • CRISPR screens to identify synthetic lethal interactions

  • Systems biology approaches to position SCAMP3 in cellular networks

These methodologies promise to reveal SCAMP3 dynamics in unprecedented detail, potentially uncovering new functions and regulatory mechanisms that remain obscured by traditional biochemical approaches .

How can researchers address non-specific binding in SCAMP3 immunodetection?

Non-specific binding is a common challenge in SCAMP3 immunodetection that can be addressed through several optimization strategies:

• For Western Blot Applications:

  • Increase blocking time (3-5% BSA or milk in TBST for 2 hours)

  • Test multiple antibody dilutions (1:1000-1:3000 range)

  • Include 0.1% Tween-20 in antibody diluent

  • Use more stringent washing (5 x 5 minutes with TBST)

  • Validate with SCAMP3 knockout/knockdown controls

• For Immunohistochemistry/Immunofluorescence:

  • Pre-adsorb antibody with non-specific proteins

  • Use species-matched pre-immune serum during blocking

  • Perform antigen retrieval optimization (test both TE buffer pH 9.0 and citrate buffer pH 6.0)

  • Include detergent (0.1-0.3% Triton X-100) in antibody diluent

  • Employ signal amplification selectively (tyramide signal amplification)

• General Considerations:

  • Validate antibody specificity against recombinant SCAMP3

  • Compare staining patterns across multiple SCAMP3 antibodies

  • Include appropriate negative controls in each experiment

These approaches can significantly improve signal-to-noise ratio and ensure reliable SCAMP3 detection .

What are common pitfalls in quantifying SCAMP3 expression levels?

Accurate quantification of SCAMP3 expression presents several challenges that researchers should address:

• Western Blot Quantification Issues:

  • The observed molecular weight (33 kDa) differs from calculated (38.3 kDa)

  • Post-translational modifications may generate multiple bands

  • Membrane protein extraction efficiency varies between protocols

  • Loading controls should be selected carefully (membrane protein controls preferred)

• qRT-PCR Considerations:

  • Alternative splicing generates multiple isoforms requiring specific primer design

  • Reference gene selection must be validated for each experimental system

  • RNA extraction from membrane-rich compartments may require specialized protocols

• Immunostaining Quantification:

  • Subcellular localization changes may confound whole-cell measurements

  • Signal intensity depends on fixation and permeabilization conditions

  • Automated image analysis requires careful threshold setting

• Standardization Approaches:

  • Include calibration standards when possible

  • Use multiple detection methods to cross-validate findings

  • Report relative rather than absolute changes unless properly calibrated

Addressing these considerations ensures more reliable and reproducible quantification of SCAMP3 expression across experimental systems .

What are the most promising research directions for SCAMP3?

The current state of SCAMP3 research suggests several high-priority directions for future investigation:

• Structural Biology: Determining SCAMP3's three-dimensional structure would significantly advance our understanding of its function and provide templates for targeted drug development.

• Systems Biology Integration: Positioning SCAMP3 within broader cellular networks through proteomics, interactomics, and functional genomics approaches would clarify its role in health and disease.

• Therapeutic Development: Exploring SCAMP3 as a target in both cancer and infectious disease contexts represents a promising avenue with potential clinical applications.

• In Vivo Models: Developing and characterizing SCAMP3 knockout or conditional knockout animal models would provide essential insights into its physiological roles.

• Clinical Correlations: Expanding studies of SCAMP3 expression and function across diverse human pathologies could identify new disease associations and biomarker applications.

These research directions collectively promise to advance our fundamental understanding of SCAMP3 biology while potentially yielding translational benefits in multiple disease contexts .

How can researchers contribute to the standardization of SCAMP3 research methodologies?

Standardization of SCAMP3 research methodologies would accelerate progress in this field and improve cross-study comparability:

• Antibody Validation: Comprehensive validation of SCAMP3 antibodies across multiple applications and experimental systems using knockout controls.

• Protocol Repositories: Establishment of detailed, reproducible protocols for SCAMP3 detection, quantification, and functional analysis accessible to the research community.

• Reference Materials: Development of recombinant SCAMP3 standards and calibration materials for quantitative applications.

• Consistent Terminology: Adoption of uniform nomenclature for SCAMP3 isoforms, domains, and functional states.

• Data Sharing: Contribution to public repositories of SCAMP3-related datasets, including proteomic, transcriptomic, and imaging data.